William F. Hamilton
Chairman bij MentorTech Management LLC
Profiel
Dr. William F.
Hamilton is Independent Director at Arno Therapeutics, Inc., a Professor at University of Pennsylvania, Chairman at MentorTech Management LLC, a Trustee & International VP-Eastern Region at International Brotherhood of Teamsters, a Director-Jerome Fisher Program at The Wharton School of the University of Pennsylvania, and a Director-Jerome Fisher Program at School of Engineering & Applied Science.
He is on the Board of Directors at Arno Therapeutics, Inc., International Brotherhood of Teamsters, Neuro Diagnostic Devices, Inc., and Ceptaris Therapeutics, Inc.
Dr. Hamilton was previously employed as Lead Director by NovaDel Pharma, Inc. He also served on the board at Neose Technologies, Inc., Avid Radiopharmaceuticals, Inc., and Neuronyx, Inc.
Dr. Hamilton received his undergraduate degree from the University of Pennsylvania, a graduate degree from the University of Pennsylvania, an MBA from the University of Pennsylvania, and a doctorate degree from the London School of Economics & Political Science.
Actieve functies van William F. Hamilton
Bedrijven | Functie | Begin |
---|---|---|
MentorTech Management LLC
MentorTech Management LLC Investment ManagersFinance MentorTech Management LLC (MentorTech Ventures) is an independent venture capital firm founded in 2005 by Michael B. Aronson and Boris M. Kalandar. The firm is headquartered in Philadelphia, Pennsylvania. | Chairman | - |
The International Brotherhood of Teamsters
The International Brotherhood of Teamsters Miscellaneous Commercial ServicesCommercial Services International Brotherhood of Teamsters operates a labor diverse union. It represents employees in transportation, freight-related and other industries. The firm operates under federal supervision. The company was founded in 1903 and is headquartered in Washington, DC. | Corporate Officer/Principal | - |
Ceptaris Therapeutics, Inc.
Ceptaris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ceptaris Therapeutics, Inc. develops mechlorethamine gels. The firm develops a gel formulation of mechlorethamine hydrochloride for the treatment of early stage (stages I-IIA) mycosis fungoides, a type of Cutaneous T-Cell Lymphoma. The company was founded in 2002 and is headquartered in Malvern, PA. | Director/Board Member | - |
University of Pennsylvania | Corporate Officer/Principal | 01-01-1967 |
The Wharton School of the University of Pennsylvania | Corporate Officer/Principal | - |
School of Engineering & Applied Science | Corporate Officer/Principal | - |
Eerdere bekende functies van William F. Hamilton
Bedrijven | Functie | Einde |
---|---|---|
Neose Technologies, Inc.
Neose Technologies, Inc. Pharmaceuticals: MajorHealth Technology The Group's principal activity is to develop proprietary drugs, focusing primarily on therapeutic proteins. Its technologies to develop proprietary versions of protein drugs with proven safety and efficacy and to improve the therapeutic profiles of proteins being developed. Its proprietary drug development portfolio currently consists of two therapeutic protein candidates.GlycoPEG-EPO (NE-180) is a long-acting version of erythropoietin (EPO) produced in insect cells. EPO is prescribed to stimulate production of red blood cells, and it gives treatment of chemotherapy-induced anemia and anemia associated with chronic renal failure. Its second proprietary protein, GlycoPEG-GCSF, is a long-acting version of granulocyte colony stimulating factor G-CSF and it is prescribed to stimulate production of neutrophils (a type of white blood cell). Its trademarks are NEOSE, GlycoPEGylation and GlycoConjugation. It operates predominantly in the domestic market. | Director/Board Member | 08-07-2010 |
Neuronyx, Inc.
Neuronyx, Inc. Medical SpecialtiesHealth Technology Neuronyx, Inc. develops and distributes bone marrow derived stem cells. It also develops cellular therapies focusing on ischemic diseases to repair damaged cardiac tissues in patients suffering from heart attack. The company was founded by Hubert J.P. Schoemaker in 1999 and is located in Malvern, PA. | Director/Board Member | 13-10-2009 |
ARNO THERAPEUTICS, INC. | Director/Board Member | - |
░░░░░ ░░░░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
░░░░ ░░░░░░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Opleiding van William F. Hamilton
University of Pennsylvania | Graduate Degree |
London School of Economics & Political Science | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
ARNO THERAPEUTICS, INC. | Health Technology |
Bedrijven in privébezit | 8 |
---|---|
The International Brotherhood of Teamsters
The International Brotherhood of Teamsters Miscellaneous Commercial ServicesCommercial Services International Brotherhood of Teamsters operates a labor diverse union. It represents employees in transportation, freight-related and other industries. The firm operates under federal supervision. The company was founded in 1903 and is headquartered in Washington, DC. | Commercial Services |
Neose Technologies, Inc.
Neose Technologies, Inc. Pharmaceuticals: MajorHealth Technology The Group's principal activity is to develop proprietary drugs, focusing primarily on therapeutic proteins. Its technologies to develop proprietary versions of protein drugs with proven safety and efficacy and to improve the therapeutic profiles of proteins being developed. Its proprietary drug development portfolio currently consists of two therapeutic protein candidates.GlycoPEG-EPO (NE-180) is a long-acting version of erythropoietin (EPO) produced in insect cells. EPO is prescribed to stimulate production of red blood cells, and it gives treatment of chemotherapy-induced anemia and anemia associated with chronic renal failure. Its second proprietary protein, GlycoPEG-GCSF, is a long-acting version of granulocyte colony stimulating factor G-CSF and it is prescribed to stimulate production of neutrophils (a type of white blood cell). Its trademarks are NEOSE, GlycoPEGylation and GlycoConjugation. It operates predominantly in the domestic market. | Health Technology |
NovaDel Pharma, Inc.
NovaDel Pharma, Inc. Pharmaceuticals: MajorHealth Technology NovaDel Pharma, Inc. engages in developing oral spray formulations for different types of drugs. It develops oral spray and pharmaceutical products for angina pectoris, insomia, migraine headaches, and disorders of the central nervous system. The company was founded in 1982 and is headquartered in Bridgewater, NJ. | Health Technology |
Neuronyx, Inc.
Neuronyx, Inc. Medical SpecialtiesHealth Technology Neuronyx, Inc. develops and distributes bone marrow derived stem cells. It also develops cellular therapies focusing on ischemic diseases to repair damaged cardiac tissues in patients suffering from heart attack. The company was founded by Hubert J.P. Schoemaker in 1999 and is located in Malvern, PA. | Health Technology |
Avid Radiopharmaceuticals, Inc.
Avid Radiopharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Avid Radiopharmaceuticals, Inc. provides molecular imaging services. It develops new molecular imaging agents capable of changing the medical management of significant, chronic human diseases by identifying the first stages of pathological change, potentially assisting in earlier diagnosis, and better management and development of new therapies. The company was founded by Daniel M. Skovronsky in 2004 and is headquartered in Philadelphia, PA. | Health Services |
Ceptaris Therapeutics, Inc.
Ceptaris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ceptaris Therapeutics, Inc. develops mechlorethamine gels. The firm develops a gel formulation of mechlorethamine hydrochloride for the treatment of early stage (stages I-IIA) mycosis fungoides, a type of Cutaneous T-Cell Lymphoma. The company was founded in 2002 and is headquartered in Malvern, PA. | Health Technology |
MentorTech Management LLC
MentorTech Management LLC Investment ManagersFinance MentorTech Management LLC (MentorTech Ventures) is an independent venture capital firm founded in 2005 by Michael B. Aronson and Boris M. Kalandar. The firm is headquartered in Philadelphia, Pennsylvania. | Finance |
Neuro Diagnostic Devices, Inc.
Neuro Diagnostic Devices, Inc. Medical SpecialtiesHealth Technology Neuro Diagnostic Devices, Inc. provides medical devices. Its product ShuntCheck is an aid to the detection of flow in implanted cerebrospinal fluid (CSF) shunts. The company was founded by Samuel R. Neff and Frederick J. Fritz on May 16, 2005 and is headquartered in Princeton, NJ. | Health Technology |